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Abstract
Undergraduate students studying the Bachelor of Radiation Therapy at Queens-
land University of Technology (QUT) attend clinical placements in a number
of department sites across Queensland. To ensure that the curriculum prepares
students for the most common treatments and current techniques in use in
these departments, a curriculum matching exercise was performed. A cross-sec-
tional census was performed on a pre-determined “Snapshot” date in 2012.
This was undertaken by the clinical education staff in each department who
used a standardized proforma to count number of patients as well as prescrip-
tion, equipment, and technique data for a list of tumour site categories. This
information was combined into aggregate anonymized data. All 12 Queensland
radiation therapy clinical sites participated in the Snapshot data collection exer-
cise to produce a comprehensive overview of clinical practice on the chosen
day. A total of 59 different tumour sites were treated on the chosen day and as
expected the most common treatment sites were prostate and breast, compris-
ing 46% of patients treated. Data analysis also indicated that intensity-modu-
lated radiotherapy (IMRT) use is relatively high with 19.6% of patients
receiving IMRT treatment on the chosen day. Both IMRT and image-guided
radiotherapy (IGRT) indications matched recommendations from the evidence.
The Snapshot method proved to be a feasible and efficient method of gathering
useful data to inform curriculum matching. Frequency of IMRT use in Queens-
land matches or possibly exceeds that indicated in the literature. It is recom-
mended that future repetition of the study be undertaken in order to monitor
trends in referral patterns and new technology implementation.
Introduction
Undergraduates studying the Bachelor of Radiation Ther-
apy at Queensland University of Technology (QUT)
undertake clinical placements in a variety of department
sites, where they are exposed to a wide range of tech-
niques and technologies. Although this offers numerous
advantages in terms of a wide-ranging clinical experience
and exposure to different equipment and procedures,
there are challenges associated with ensuring undergradu-
ates attend an appropriate mix of placements. One chal-
lenge is that placement sites differ in patient case-mix
and thus in their opinion of “common” and “routine”
treatments. Part of this may be due to radiation onco-
logist referral patterns and speciality; hence, changes in
referral pattern in one centre may not necessarily be
reflected in other centres. From an academic planning
perspective, there is a risk that this bias in referral pat-
terns may filter through to curriculum content if feedback
is sought from individual clinical centres. A curriculum is
a “dynamic process that needs to be reviewed constantly”
[1]. It is vitally important that educational curricula
remain current and swiftly react to changes, particularly
against the background of the rapidly evolving world of
radiation therapy. While horizon-scanning reports and
surveys [2, 3] provide useful technical alerts, more subtle
changes to statewide treatment patterns and widespread
use of technologies is more difficult to detect. The focus
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of most of these reports is on the distribution of new
equipment rather than implementation and frequency of
use. In order to more closely match the curriculum to
statewide clinical practice requirements and better prepare
the students for their supervised practice year, a data
collection exercise was undertaken as a collaboration
between academic staff and radiation therapy clinical
educators across Queensland.
Aims
The primary aim for the study was to collect current
clinical practice information to inform curriculum map-
ping exercises. This was performed in order to ensure
that appropriate weighting was applied to the most com-
mon treatments and most current techniques. A second-
ary aim was to provide a baseline of current technology
usage across Queensland for future trend monitoring
exercises.
Methods
The data collection harvested quantitative patient treat-
ment data on a single selected “Snapshot” day on 7
March 2012, across all radiation therapy clinical place-
ment sites in Queensland. A date of convenience was cho-
sen by the researcher without consultation from clinical
departments in order to reduce selection bias. All radio-
therapy providers within Queensland were chosen as these
are the primary clinical placement centres for students on
the QUT Course. It was important to ensure that the data
reflected the range of techniques that the students would
be exposed to during placements. Because of this sam-
pling was deemed inappropriate and a census approach
was utilized to collect data from all the sites. An Excel
proforma was developed to enable tabulation of number
of patients, prescription, and simple technique data for a
range of tumour sites. The spreadsheet was populated
with a draft list of 60 common tumour sites. These were
determined following discussion with clinical staff from
various Queensland departments. The census was per-
formed collaboratively by the clinical educators and aca-
demic staff, and local educators were responsible for
ensuring accurate data collection3 . Data were collected in
order to provide information about the relative propor-
tions of treatments as well as use of more specialist tech-
nology or techniques. Data collection techniques were
varied according to the systems in place locally; some
centres performed manual data collation, whereas others
designed database queries to collect information directly
from the verification system. All data were electronically
forwarded to the research lead then immediately anony-
mized and collated in order to generate purely accumula-
tive quantitative information. The audit and subsequent
publication was determined to be exempt from the need
for University Human Research Ethics Committee review,
approval, and monitoring in conformity with sections
5.1.22 and 5.1.23 of the National Statement on Ethical
Conduct in Human Research. Descriptive data analysis
was conducted using Excel statistical functions. After data
analysis curriculum mapping was performed with the
existing tumour sites, technique, planning, and technol-
ogy topics being mapped from the content list of each
“radiation oncology” and “radiotherapy planning” unit in
the course. Since the curriculum is vertically integrated
(thus understanding is developed over time), it was
important to further collate elements of these topics from
different parts of the course so that numbers of teaching
sessions and hours dedicated to each topic could be listed.
Once this process was complete, the “Snapshot” data were
incorporated into the map. The aims of the mapping
were to highlight gaps in the existing content material
and discrepancies between the teaching hours and clinical
prevalence for different oncology, technique, and planning
topics.
Results
Demographics
All 12 Queensland radiation oncology clinical sites were
able to provide data to produce a comprehensive over-
view of clinical practice on the chosen day. A total of
1014 patients were treated on the chosen day, including
108 patients receiving electron therapy and five undergo-
ing kilovoltage (kV) radiotherapy.
Most common treatment sites
A total of 59 different tumour sites were treated on
the chosen day. The original list of 60 categories cov-
ered most of the different anatomical sites as well as
distinguishing between radical and palliative treatments.
In addition to the stated categories, an “other” category
was provided. Treatment sites listed under this other
category included orbit, ear, plasmacytoma, angiosarco-
ma, face, and squamous cell carcinomas (SCCs) of the
mandible and floor of mouth. Categories that were not
treated on the chosen day included liver secondary,
myeloma, ocular melanoma, ovary, small bowel, spleen,
testes, thymus, thyroid, trachea, and vagina. The most
commonly treated sites (those with over 10 patients
per day) are summarized in Table 1. As expected,
breast and prostate together comprise a significant pro-
portion (46%) of statewide workload (467 of 1014
treatments).
2 ª 2013 Australian Institute of Radiography.
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Resource use
Intensity-modulated radiotherapy
Data were harvested relating to use of static gantry inten-
sity-modulated radiotherapy (IMRT), arc-based IMRT
(comprising volumetric arc therapy [VMAT], RapidArc,
and tomotherapy), stereotactic radiotherapy, 4D CT
(four-dimensional computed tomography), and fusion
technology. This information was primarily intended to
provide a baseline for future comparison to show how
technology use is changing across the State. Table 2 illus-
trates the reported use of technology on the “Snapshot”
day. It can be seen that uptake of IMRT is relatively high
(199 of 1014 treatments).
The data were further analysed to determine which cat-
egories of treatment were the prime indicators for IMRT
as illustrated in Table 3. This revealed that, as expected,
prostate (78) and breast (28) dominated, with paediatric,
brain, and head and neck sub-categories also being typical
candidates. However, when all the conventional “head
and neck” sub-categories were combined into a “head
and neck” category, there were 40 patients receiving
IMRT, actually making this the second most common
indication after prostate.
Table 1. Most common treatments 4.
Treatment site Number of patients
Breast tangents 187
Prostate/prostate bed 126
Prostate and seminal vesicles 83
Breast tangents and nodes 71
Lung primary 62
Skin SCC 58
Bone secondary 48
Rectum 38
Brain primary 31
Brain secondary 25
Oesophagus 21
Cervix 19
Lymphoma, non-Hodgkin 19
Larynx 17
Parotid 15
Melanoma 14
Bladder 13
Lymph nodes secondary 12
Skin BCC 12
Soft tissue sarcoma 12
Tongue 12
Tonsil 11
Uterus 11
SCC, squamous cell carcinoma; BCC, basal cell carcinoma.
Table 2. Technology use.
Technology Number of patients, n (%)
4DCT planning 5 (0.5)
MR fusion 69 (6.8)
PET fusion 114 (11.2)
Static gantry IMRT 122 (12)
Arc (tomotherapy, VMAT etc) 77 (7.6)
Stereotactic radiotherapy 3 (0.3)
4DCT, four-dimensional computed tomography; MR, magnetic reso-
nance; PET, positron emission tomography; IMRT, intensity-modulated
radiotherapy; VMAT, volumetric arc therapy.
Table 3. IMRT and arc indications.
Tumour site Patient numbers
IMRT indications
Prostate 50
Breast 28
Brain primary 8
Tonsil 7
Tongue 5
Larynx 4
Skin SCC 3
Oropharynx 3
Rectum 2
Cervix 2
Lymph nodes (secondary) 2
Benign tumours 2
All head and neck 20
Arc therapy indications
Prostate 28
Tongue 5
Larynx 4
Paediatric (not CNS) 4
Brain primary 3
Tonsil 3
Skin SCC 3
Oropharynx 3
Hypopharynx 3
Cervix 2
Oesophagus 2
Whole CNS 2
All head and neck 20
Combined IMRT
Prostate 78
Head and neck 40
Breast 28
Skin SCC 6
Paediatric 4
Cervix 4
Brain 3
IMRT, intensity-modulated radiotherapy; SCC, squamous cell carci-
noma; CNS, central nervous system.
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Imaging
Table 2 indicates that 183 (18%) patients had undergone
image fusion as part of their planning process. It should
be noted that these numbers relate to numbers of patients
on treatment who had image fusion performed during
their planning process as opposed to the number of
actual fusions performed on the chosen day. Positron
emission tomography (PET) fusion appears to be more
widely used than magnetic resonance (MR) fusion. The
indications for fusion were tabulated (Table 4) and
revealed that brain and rectum were the strongest indica-
tors for MR fusion, with lung, rectum, and oesophagus
leading the PET indications.
Departments were also asked to provide data concern-
ing their use of image-guided radiotherapy technology
(IGRT) including weekly and daily electronic portal
images (EPI), planar kV, cone-beam computed tomogra-
phy (CBCT), and fiducial markers (seeds). Figure 1 illus-
trates the frequency of use of these modalities. The most
common imaging modalities used were clearly planar
based EPI (311 patients for weekly and daily combined)
and kV (231 patients) with volumetric (CBCT) being per-
formed for 86 patient cases. Data demonstrate that there
were 106 patients with implanted seeds that could be used
to facilitate setup. These were almost entirely (98%) pros-
tate patients with one secondary bone and one brain pri-
mary also having seeds.
Curriculum mapping
Some valuable data were collected in order to perform
accurate curriculum mapping and as a result of the exer-
cise a number of key changes were made to the Course
curriculum as seen in Table 5.
Discussion
Impact of “Snapshot” data on curriculum
The rationale for the “Snapshot” study was primarily to
inform academic curriculum planning. From an academic
perspective, the data analysis has resulted in a renewed
confidence in curriculum matching. The data have
enabled production of an “essential tumour sites” list to
focus teaching of oncology, technique, and clinical prac-
tice. In addition, this list can be used to help guide stu-
dents’ clinical experiences, such as choice of case studies.
It is important to note that the data have been used with
a significant caveat, which is that a low incidence of a
technique or tumour site on the assigned day does not
necessarily confirm a low overall incidence. As a result no
tumour site material has been dropped from the curricu-
lum, although the relative emphasis for different sites has
been realigned. Less common sites, as identified by the
“Snapshot” data, are still included in the curriculum but
have a reduced teaching time commitment, relying more
on self-directed learning such as online presentations and
formative tests. Future iterations will be used to reinforce
Table 4. Fusion indications.
Site Patient numbers
MR fusion
Brain primary 14
Rectum 11
Prostate 8
Brain secondary 5
Skin SCC 4
Lung primary 3
Oropharynx 3
Soft tissue sarcoma 3
Bone secondary 2
Larynx 2
Uterus 2
PET fusion
Lung primary 31
Rectum 12
Oesophagus 12
Tonsil 7
Tongue 6
Skin SCC 5
Oropharynx 5
Larynx 4
Brain secondary 3
Hypopharynx 3
Melanoma 3
Lymphoma, NHL 3
Prostate 2
Cervix 2
MR, magnetic resonance; PET, positron emission tomography; SCC,
squamous cell carcinoma; NHL, non-Hodgkin’s lymphoma.
Figure 1. 10Frequency of image-guided radiotherapy technology use.
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this newly allocated timing if low incidence of these
tumour sites proves to be consistent.
One of the major outcomes from the study has been
an increase of input into IMRT teaching to ensure that
the range of sites used for planning experience represent
clinical use of the technology. Additional IMRT planning
practicals now build on existing prostate experience with
new head and neck, and breast planning practicals also
being incorporated. Given the relatively high incidence of
arc-based IMRT techniques, student experience and
teaching related to this technology has been increased.
Another outcome relates to provision of PET fusion expe-
riences to ensure that fusion of lung, rectum, and oesoph-
agus are added to the practical experience curriculum.
While it is important that students are prepared for clini-
cal practice globally, the aim of the undergraduate course
in Queensland is to better prepare students for their
supervised practice year. Therefore, it is crucial that the
range of experience and teaching materials available
matches national and statewide practice.
Clearly, the increased teaching of these newer tech-
niques can only take place in conjunction with a reduc-
tion in teaching elsewhere and this is always a challenge
for curriculum development. “Older” techniques may still
be in use clinically and remain valuable learning opportu-
nities for students to consolidate underpinning radiother-
apy principles. The challenge therefore lies with extending
new content, while maintaining underpinning knowledge
and understanding. This challenge is particularly prevalent
in a rapidly developing profession such as radiation ther-
apy. The approach taken with the planning topics
involved changing technique teaching for some tumour
sites from conventional three-dimensional (3D) confor-
mal to IMRT. Rather than removing content, the
approach concentrated on bringing the underpinning
IMRT concept teaching forward and introduce IMRT
techniques into some planning practicals. For the oncol-
ogy teaching, no content was removed but instead the
teaching approach was amended to phase out the
resource intensive face-to-face approach for the less com-
mon sites in favour of directed independent learning. For
all changes made to the curriculum, the distinction was
made between teaching of content and learning of skills.
However, content remains specific to individual tumour
sites, for example, skills learnt from some planning tech-
niques are easily transferred to others. Thus, wider imple-
mentation of IMRT planning practice did not entail
reduction in teaching content but rather a change in
approach to technique for some tumour sites, mirroring
the change in clinical practice.
IMRT use
The data not only provided curriculum matching informa-
tion but also revealed an insight into technology imple-
mentation across the state; in particular, trends in IMRT
use. IMRT is a treatment technique that can be delivered
using a variety of technologies including multiple linear
accelerator static fields [4], linear accelerator based VMAT
[5] 5, and dedicated tomotherapy equipment [6].
Snapshot data suggest that 20% of all Queensland radi-
ation therapy patients receive IMRT. Of these, the greatest
proportion of IMRT cases planned were prostate (39%),
head and neck (20%), and breast (14%). More specifi-
cally, prostate data included all patients planned for
radical radiation therapy to the prostate, prostate bed, or
prostate and seminal vesicles. The “head and neck”
category included primary tumours arising in the
Table 5. Curriculum changes.
Content Snapshot finding Resultant change
IMRT planning Very widespread use for prostate,
breast, head and neck
Earlier introduction of IMRT technique teaching to planning
units. Extended practical experience with IMRT prostate
to now include breast and head and neck planning in
planning units
Image fusion Brain and rectum strong indicators
for CT-MR fusion.
Extension of image fusion practical experience to include
CT-MR for rectum
Lung, rectum, and oesophagus good
indicators for CT-PET fusion
Extension of CT-PET fusion practical experience to include
rectum and oesophagus
Arc therapy Widespread use of volumetric arc therapy Increased teaching related to use of arc techniques and
practical planning experience.
Common tumour sites Reduced incidence of some tumour sites Reduction in teaching hours for less common tumours and
shift towards directed independent learning for these sites.
Compilation of “essential” tumour list to direct student
achievements.
IMRT, intensity-modulated radiotherapy; CT, computed tomography; MR, magnetic resonance; PET, positron emission tomography.
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nasopharynx, hypopharynx, oropharynx, larynx, parotid,
thyroid, tongue, and tonsil, while “breast” results
included all patients receiving radiotherapy to breast
tangential fields and breast tangents with nodal fields. The
focus of this discussion is to provide comparison of the
Queensland “Snapshot” results with current practice
elsewhere as reported in the literature.
In a 2009 United Kingdom study [7], the authors
reported the top three tumour types receiving IMRT: ear,
nose, and throat (ENT) 36%, urological (33%), and
breast (29%). Comparisons between these and “Snapshot”
results are difficult and somewhat unreliable because the
authors use different tumour categories and do not clarify
which tumour sites are included in these categories, for
example, “ENT” and “urological.” This variation in classi-
fication is a potential issue that thwarts true comparison,
although it can be seen that the main indications for
IMRT are broadly similar. It is interesting to note that
97% of the United Kingdom IMRT case-mix was related
to these three categories, but the “Snapshot” results indi-
cate a wider range of IMRT indications as the top three
categories only comprise 73% of cases. This suggests
wider uptake of the technology along with the growing
clinical experience and evidence base since 2007. Also,
it must be noted that much of the United Kingdom data
(like the Australian Horizon-scanning reports [3]) focuses
on numbers of centres utilizing IMRT as opposed to
number of patients receiving it.
Head and neck IMRT
Snapshot data suggest that 56% of Queensland radiation
therapy head and neck patients received IMRT. Contrast-
ing this with trends in the use of IMRT in head and neck
region in the United States of America, Sher et al. [8]
reported that 15% of head and neck patients were treated
using IMRT in the years 2000 to 2005. However, in a
broader and more generalized head and neck study, Gua-
dagnolo et al. [9], using the same patient age group, data
base, and year span, reported that 21.3% of patients were
treated using IMRT. Guadagnolo et al. defined the cohort
to include “oral cavity (including lip, tongue, floor of
mouth, gum, or the other mouth), oropharynx (including
tonsil), nasopharynx, hypopharynx, salivary gland, and
other unspecified oral cavity and pharynx”, whereas Sher
focused on non-metastatic squamous cell tumours of the
head and neck including laryngeal tumours. The differ-
ence in the results of these two studies is potentially due
to a difference in cohort definition. This is clearly a
potential problem when attempting comparisons. This
can be reduced by adhering to rigid guidelines for these
definitions. Sher et al. [8] stated that the larynx was omit-
ted from the other study because of the perception that
“patients with larynx cancer were less likely to receive
IMRT.”
In relation to this study, the importance of the larynx
being included in the head and neck figures is clearly
demonstrated. Snapshot data suggest that radiation treat-
ment to the larynx represents 24% of the total number of
head and neck cases treated, and of these, 47% were trea-
ted with some form of IMRT. Irrelevant of difference in
cohort definition, both Sher et al. [8] and Guadagnolo
et al. [9] reported a 39–45% increase in the use of IMRT
between 2000 and 2005, respectively, with both predicting
that IMRT use will exceed these figures in the future.
It would therefore be reasonable to suggest that, in
Queensland, the use of IMRT in the head and neck
region will also continue to increase in future years.
Prostate IMRT
The “Snapshot” results indicate that 37% of prostate
tumours receiving radiotherapy underwent IMRT. It is
interesting to compare this with the situation in the Uni-
ted States of America, where the treatment of prostate
tumours using IMRT is currently the subject of much
debate. Currently, there are studies [10, 11] and reports
in the media [12] suggesting that the rapid increase in
the use of prostate IMRT is due to higher Medicare reim-
bursement costs as compared with other less expensive
treatments, for example, conventional forward-planned
radiation therapy. Although much of the support for this
comes from less reliable sources, it remains clear that
reimbursement has the potential to influence practice.
Aside from this reason being posed as having a significant
and continued effect on the uptake of prostate IMRT in
the United States of America, there is considerable sup-
port for the continued use of IMRT based on evidence of
reduced gastrointestinal morbidity and hip fractures and
the potential for better cancer control through the deliv-
ery of higher target doses through greater field conformity
[11, 13, 14]. Nguyen et al. [10] reported the rapid uptake
of IMRT for men diagnosed with non-metastatic prostate
cancer, with a rise from 28.7% in 2002 to 81.7% in 2005.
This is substantially higher than the Queensland results
and may indicate the impact of the United States billing
system. Comparatively, Sheets et al. [13] reported that the
use of IMRT increased relative to conformal radiation
therapy from 0.15% in 2000 to 95.7% in 2008. In Austra-
lia, the Royal Australian and New Zealand College of
Radiologists (RANZCR) recommend that some form of
IMRT is available in every radiation oncology department
and is considered in the treatment of tumours involving
the prostate or prostate and seminal vesicles [3, 5].
In conjunction with the evidence for the continued use
of IMRT in the treatment of prostate tumours, the
6 ª 2013 Australian Institute of Radiography.
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Australian Institute of Health and Welfare (AIHW) pre-
dicts that prostate cancer will remain the most common
male cancer diagnosed in 2020 [15]. The AIHW also pre-
dicts that between 2011 and 2020, national prostate can-
cer diagnoses will continue to increase from three cases
per 100,000 each year to somewhere between 164 and 200
cases per 100,000. These figures, combined with expected
population changes, equate to approximately 28,000 new
cases being diagnosed in 2020 [15]. Clearly, prostate
radiotherapy is destined to remain one of the main uses
of IMRT techniques, and it will be interesting to see how
the percentage of patients with prostate cancer receiving
IMRT changes in future iterations of the study.
Breast IMRT
In Queensland, it seems that breast IMRT is less wide-
spread than head and neck or prostate with only 11% of
this group of patients receiving treatment using this tech-
nology. IMRT is commonly used to treat patients with
breast cancer in order to produce a more homogenous
dose distribution, minimize rib dose, restrict lung volume
and dose, and to reduce cardiac toxicity if treating the left
breast [16]6 . In a 2011 study focusing on trends in the use
of IMRT to treat the whole-breast, Smith et al. [17]
argued that more simplistic non-IMRT techniques may
be sufficient, regardless of studies demonstrating that
IMRT reduces acute skin reaction and improves long
term skin cosmesis [18]. Using the same Medicare data-
base as in the United States of America prostate studies,
Smith et al. [17] reported an increase in breast IMRT
rates from 0.9% in 2001 to 11.2% in 2005. These figures
cannot be used to predict local use of this technology as
the USA reimbursement policy has arguably a strong
influence on the adoption of IMRT in the treatment of
breast cancer [17]. An important distinction should per-
haps be made between left and right breast IMRT use,
with cardiac sparing being a strong indication for IMRT
use on the left side [19]. It would be interesting to collect
data relating to IMRT for each side independently for
future Snapshot analysis.
Recently, the AIHW report [15] predicted that female
breast cancer will continue to remain the most common
cancer diagnosed in 2020. Additionally, breast cancer
diagnoses will remain constant between 2011 and 2020 at
114 new cases per 100,000 female population. Not to be
overlooked yet far less common, male breast cancer diag-
noses will contribute 0.002 new cases per 100,000 of the
Australian male population. Taking into account expected
population growth, the number of new cases of breast
cancer will continue to increase from approximately
14,000 (2011) to 17,000 (2020) [15]. When taking into
consideration the known benefits of breast IMRT and
national predictions in cancer incidence, it would seem
reasonable to conclude that breast IMRT is most likely to
be used in cases where superior dose homogeneity is
critical and for left-sided disease to reduce cardiac toxicity
[19].
Summary of IMRT use
The purpose of this study was to evaluate local current
trends in the use of available techniques and technologies
so that appropriate weighting could be applied in the aca-
demic and clinical curriculum. The first iteration of the
study has provided a useful baseline which forms the
basis for this paper’s discussion. Synthesis of the data
combined with the RANCZR recommendation that some
form of IMRT be available in every radiation oncology
department [3] demonstrates that IMRT is and will
remain an important technology in cases where tumour
size, location, adjacent organs, and dosimetry are critical
for the patient to receive an optimal treatment outcome.
The results of the Snapshot study would seem to indicate
that IMRT use in Queensland is consistent with global
data. The results also indicate that arc-based IMRT cur-
rently represent 39% of IMRT treatments; it will be inter-
esting to repeat this in the future to identify trends in the
techniques and technologies used to deliver IMRT.
IGRT use
The data suggest that electronic portal imaging (EPI) is
still the dominant technology underpinning IGRT use
when compared with planar kV and CBCT. CBCT is a
relatively new imaging modality and is clearly not in use
at all centres. When the indications for CBCT on the
studied day are examined it remains clear that most
CBCT images are taken for head and neck (33%) with
prostate and seminal vesicle patients (23%) and prostate
only (9%) the next most common indications. It will be
interesting to see how this pattern develops in future
studies as CBCT is clearly growing into a more common
modality [20]. Similarly, planar kV is less well established
than MV 7EPI. It is thus highly likely that the “Snapshot”
results mirror the availability of the different modalities
and it will be interesting to see how this balance changes
in future iterations of the study. It would also be of value
to include tomotherapy imaging as one of the categories
for IGRT as this technology is increasingly becoming
more widespread.
Head and neck IGRT
Although data from the “Snapshot” day cannot reveal
long-term patterns in IGRT practice, it can provide an
ª 2013 Australian Institute of Radiography. 7
P. Bridge et al. Snapshot Curriculum Matching
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
indication of which tumour sites are most likely to be
subject to regular imaging; especially those following a
daily imaging protocol. In the head and neck region,
research [21] has shown that daily imaging unsurprisingly
increases accuracy and crucially allows for a reduction in
planning target volume (PTV) expansion margin. “Snap-
shot” data suggest that clinical practice generally follows
these recommendations for some sites with 100% of ton-
gue, tonsil, hypopharynx, and nasopharynx patients being
imaged on the study day. Only 8 of the 15 parotid
patients and 11 of 17 larynx patients underwent imaging.
This is perhaps surprising given the potential for tumour
response and the normally small PTV margins for these
sites but only really demonstrates that daily imaging has
not been performed. This could be linked to the small
number of these patients being treated with IMRT but
more in-depth analysis is impossible with aggregate data.
It remains clear, however, that IGRT for head and neck
cancer is well established across the state.
Prostate IGRT
Another common indication for IGRT is prostate where
decreased toxicity and potential dose escalation can be
achieved [22], and the evidence base here is also strongly
in favour of daily imaging, particularly for IMRT patients
[23]. The random positional error for these organs
demands a daily IGRT protocol if small margins are used.
There is evidence in particular that highlights the impor-
tance of daily imaging for seminal vesicle involved patients
due to the high interfraction motion and deformation of
these structures [24]. “Snapshot” data revealed that imag-
ing took place on the studied day for 89% of prostates and
87% of “prostate and seminal vesicle” patients. Interest-
ingly, 19% of prostate and 15% of prostate and seminal
vesicle images on the studied day were classified as weekly
EPI. Again, it must be borne in mind that the data can
only suggest the presence of daily imaging protocols and
frequency of other protocols cannot be inferred. But cer-
tainly, it can be seen that most prostate patients are sub-
jected to IGRT, although perhaps further study into the
range of different imaging protocols is warranted.
Snapshot methodology
A cross-sectional census without sampling was used to
gain an overview of current practice. Similar methods are
used for population census data collection, and it is
important to acknowledge the limitations as well as the
advantages of these techniques. The main advantage is the
ability to gather data that are tailored to purpose. When
comparing to an alternative approach such as annual
reporting data, it allows for distinct and useful categories
of data to be used. Attempting the same data interpreta-
tion based on International Classification of Disease (ICD)
codes, for example, is fraught with difficulties relating
these to radiation therapy techniques and technologies.
One concern of data collection is the impact on clinical
staff and for most departments Snapshot proved to be a
relatively quick and convenient method with reported
times for full department data collection in the region of
4 hours. For some departments, however, this figure varied
considerably according to the size of department, quality
of data input, and levels of automation. Automatic data
collection from verification systems and coding databases
could offer more rapid outcomes in the future. However,
as previously discussed, these methods may potentially
limit the usefulness of the data. Another potential
approach would be to gather summary data using the
same categories as “Snapshot” but over an extended period
such as a week, month, or calendar year. This would
clearly be an extremely time consuming exercise.
The quantity of data harvested can also be a challenge.
By using broad categories, the data analysis can be simpli-
fied and trends more easily identified. Even with this itera-
tion of the tool the data analysis was a lengthy process.
A balance must be struck between high enough levels of
detail and ease of use. This method is ideal for relatively
broad categories but the small numbers of patients falling
into highly specific categories, including staging informa-
tion, for example, would frustrate attempts at trend spot-
ting. Identification of the most appropriate categories is
obviously the key to a successful and appropriate census
tool.
By its very nature, census data based on a single day
can miss very low incidence tumour sites, and in this
case, no patients were being treated for liver secondary,
myeloma, ocular melanoma, ovary, small bowel, spleen,
testes, thymus, thyroid, trachea, and vaginal tumours.
Care must be taken to ensure that a lack of incidence on
the “Snapshot” day is not taken to mean that these treat-
ments do not occur. A potential issue could be whether
the time of year affects referral rates. It is unlikely yet
possible that referral rates change throughout the year
and thus influence “Snapshot” data. Three approaches to
this may be considered. Repeating the exercise several
times throughout the year may highlight referral trends.
Alternatively, maintaining the same date for future itera-
tions will ensure that any such variations do not influence
trend spotting. Finally, it may be of value to repeat the
audit at two separate dates within each year. Further
investigation is needed to identify if referral patterns are a
significant problem.
It would be useful from an academic course planning
perspective to analyse individual centre responses in order
to determine how location and status of each centre
8 ª 2013 Australian Institute of Radiography.
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affects technique and technology implementation. This
would help inform student placement choices, but the
decision to preserve centre anonymity means that this
data cannot be analysed currently. This is a potential lim-
itation, but it was deemed more important to gather data
from all the centres than just those that did not require
anonymity.
It is important to acknowledge that the curriculum
planning process is best achieved via a multi-faceted
approach including other methods such as multi-disci-
plinary consensus groups [25] or the Delphi technique
[26]. Clearly, a cross-sectional census has proven to be a
convenient method for collecting bulk data to inform
clinically relevant content. Convenient data categories can
be utilized to collect and analyse useful data. It is impor-
tant that after recommended changes have been imple-
mented future data collection uses identical data
classifications to enable future trends in technology use to
be monitored and compared.
Conclusion
The Snapshot method proved to be a feasible and efficient
method of gathering useful data to inform curriculum
matching. Changes have been made to the curriculum in
order to better reflect the clinical implementation of
IMRT, volumetric arc therapy, and image fusion tech-
niques. The results have also enabled improved mapping
of oncology teaching emphasis to clinical practice as well
as establishing a baseline with regard to treatment and
technology implementation from which to monitor future
trends. Further analysis of the first iteration data suggests
that IMRT use in Queensland is on a par with, if not
slightly ahead of, rates reported in the literature. IGRT
use has also been seen to be closely aligned with recom-
mendations from the evidence base, although this is
affected by variations in technology availability. These
findings from the “Snapshot” data have helped align cur-
riculum with current clinical practice and helped aca-
demic course planners prioritise teaching resources to the
most common techniques and technologies.
Future iterations of the method will distinguish between
left and right breast treatments as well as sub-categorise
“other” tumour sites. It will also allow tomotherapy
images to be included as a separate IGRT category. Repeti-
tion of the method in the future will enable curriculum
currency to be maintained as well as monitor trends in
technology and technique usage. It will be particularly
interesting to repeat this audit in other states and coun-
tries to provide comparative data. It is recommended that
similar studies are undertaken on a regular basis to ensure
that curriculum planners are provided with all the relevant
information to ensure currency of content is maintained.
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